Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Greiner

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Vaccine|January 30, 2007
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccinationDavid A Zaharoff, Connie J Rogers, Kenneth W Hance, et al.
Oncotarget|November 2, 2017
Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion proteinY Maurice Morillon, Scott A Hammond, Nicholas M Durham, et al.
Cytokine|October 24, 2003
Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigensClaudia Palena, Philip Arlen, Hasan Zeytin, et al.
Biomaterials|October 23, 2010
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesMichael J Heffernan, David A Zaharoff, Jonathan K Fallon, et al.
Vaccine|November 27, 2007
Chitosan solution enhances the immunoadjuvant properties of GM-CSFDavid A Zaharoff, Connie J Rogers, Kenneth W Hance, et al.
Sports Medicine (Auckland, N.Z.)|March 20, 2008
Physical activity and cancer prevention : pathways and targets for interventionConnie J Rogers, Lisa H Colbert, John W Greiner, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 19, 2008
Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunityHasan Zeytin, Eva Reali, David A Zaharoff, et al.
Cancer Immunology Research|February 28, 2016
Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint InhibitorAmanda J Vandeveer, Jonathan K Fallon, Robert Tighe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccinesKenneth W Hance, Connie J Rogers, David A Zaharoff, et al.
Cancer Research|September 5, 2002
Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic miceJohn Schmitz, Eva Reali, James W Hodge, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Vaccine|January 30, 2007
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccinationDavid A Zaharoff, Connie J Rogers, Kenneth W Hance, et al.
Oncotarget|November 2, 2017
Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion proteinY Maurice Morillon, Scott A Hammond, Nicholas M Durham, et al.
Cytokine|October 24, 2003
Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigensClaudia Palena, Philip Arlen, Hasan Zeytin, et al.
Biomaterials|October 23, 2010
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesMichael J Heffernan, David A Zaharoff, Jonathan K Fallon, et al.
Vaccine|November 27, 2007
Chitosan solution enhances the immunoadjuvant properties of GM-CSFDavid A Zaharoff, Connie J Rogers, Kenneth W Hance, et al.
Sports Medicine (Auckland, N.Z.)|March 20, 2008
Physical activity and cancer prevention : pathways and targets for interventionConnie J Rogers, Lisa H Colbert, John W Greiner, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 19, 2008
Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunityHasan Zeytin, Eva Reali, David A Zaharoff, et al.
Cancer Immunology Research|February 28, 2016
Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint InhibitorAmanda J Vandeveer, Jonathan K Fallon, Robert Tighe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccinesKenneth W Hance, Connie J Rogers, David A Zaharoff, et al.
Cancer Research|September 5, 2002
Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic miceJohn Schmitz, Eva Reali, James W Hodge, et al.
Pageof 4